© 2021 MJH Life Sciences and Cure Today. All rights reserved.
© 2021 MJH Life Sciences™ and Cure Today. All rights reserved.
May 27th 2021, 1:00pm
For patients with early-stage, unfavorable-risk Hodgkin lymphoma, this treatment option may allow for the reduction or elimination of radiotherapy in patients without malignant disease.
April 23rd 2021, 7:16pm
The FDA has approved Zynlonta (loncastuximab tesirine-lpyl) for the treatment of relapsed/refractory diffuse large B-cell lymphoma (DLBCL).
April 23rd 2021, 3:00pm
From a college student who survived lymphoma biking 4,000 miles for charity to the death of “Harry Potter” actress Helen McCrory, here’s what’s happening in the cancer landscape this week.
April 19th 2021, 9:00pm
Median progression-free survival in patients treated with Keytruda was 13.2 months versus 8.3 months with Adcetris, which makes Keytruda an “effective treatment option” for patients in this population who were either ineligible for or relapsed after autologous hematopoietic stem cell transplantation.
April 15th 2021, 9:00pm
Lymphoma survivor Nina Luker talks about receiving a diagnosis at age 24 and how sharing her story with nearly 200,000 supporters on social media helped her find purpose.
April 6th 2021, 3:00pm
Early findings show that glofitamab may be a safe and effective option for patients with pretreated, relapsed/refractory B-cell non-Hodgkin lymphoma.
March 25th 2021, 3:00pm
In this episode of the “CURE® Talks Cancer” podcast, we spoke with a large B-cell lymphoma “alumni” who was diagnosed at 24 about what it was like to be the only young patient receiving infusions at her cancer center, and what led her to start a nonprofit organization to help others along their journey.
March 22nd 2021, 9:00pm
For patients with B-cell lymphoma, the addition of Revlimid to standard R-CHOP did not improve progression-free survival nor event-free survival.
March 11th 2021, 4:00pm
This week on the “CURE® Talks Cancer” podcast, we spoke with lymphoma survivor Nina Luker about what it was like to receive a diagnosis at age 24, and how sharing her story with nearly 200,000 supporters on TikTok and Instagram led her to find purpose with the Lymphoma Research Foundation.
March 9th 2021, 7:00pm
Nearly one year ago to the day, 24-year-old Nina Luker was completely blindsided by a diagnosis of non-Hodgkin lymphoma. But after powering through treatments in the thick of the COVID-19 pandemic, Luker is now cancer-free and offering advice to those who may be looking for ways to help their loved ones through difficult times of their own.
Reducing Alcohol Consumption Leads to a ‘Plethora of Health Benefits’ Including Decreased Risk of Cancer, Expert Says
Women With Diabetes May Face Increased Kidney Cancer Risk
Common Questions on Medical Marijuana
Remission: Time to Breathe Again!